Weik Capital Management Takes $542,000 Position in Amrize Ltd $AMRZ

Weik Capital Management purchased a new position in Amrize Ltd (NYSE:AMRZFree Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,175 shares of the company’s stock, valued at approximately $542,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. purchased a new stake in shares of Amrize in the second quarter valued at $1,065,029,000. Norges Bank purchased a new stake in Amrize in the 2nd quarter worth about $670,915,000. Dodge & Cox purchased a new stake in Amrize in the 2nd quarter worth about $622,085,000. JPMorgan Chase & Co. bought a new stake in Amrize in the second quarter worth about $220,404,000. Finally, Legal & General Group Plc bought a new stake in Amrize in the second quarter worth about $161,761,000.

Amrize Stock Down 3.2%

NYSE:AMRZ opened at $61.70 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The company has a 50-day moving average of $57.33 and a 200 day moving average of $53.24. The firm has a market cap of $34.13 billion and a PE ratio of 25.08.

Amrize (NYSE:AMRZGet Free Report) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.95 billion. The business’s quarterly revenue was down .4% on a year-over-year basis.

Analysts Set New Price Targets

Several brokerages have recently weighed in on AMRZ. Vertical Research assumed coverage on Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target on the stock. Berenberg Bank set a $70.00 target price on Amrize in a research note on Thursday, February 19th. Wells Fargo & Company boosted their target price on shares of Amrize from $59.00 to $66.00 and gave the company an “overweight” rating in a research note on Thursday, February 19th. Weiss Ratings upgraded shares of Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, February 11th. Finally, Bank of America set a $58.00 price objective on shares of Amrize in a report on Monday, January 12th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $63.43.

Read Our Latest Stock Analysis on Amrize

Insider Buying and Selling

In related news, CFO Ian A. Johnston bought 1,200 shares of the stock in a transaction on Thursday, February 19th. The stock was bought at an average price of $63.92 per share, for a total transaction of $76,704.00. Following the completion of the acquisition, the chief financial officer directly owned 18,544 shares in the company, valued at approximately $1,185,332.48. This represents a 6.92% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.